
Omada Health adds connected blood pressure and blood sugar monitors to platform
The new devices are part and parcel with the programs launched by the company last year to help support the treatment of patients with hypertension and Type 2 diabetes.
The new devices are part and parcel with the programs launched by the company last year to help support the treatment of patients with hypertension and Type 2 diabetes.
The startup previously developed the Sleepio application, which is targeted at insomnia, and is offered to around 12 million users through partnerships with payers and employers like Boston Medical Center, Comcast and the NHS.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The company has signed a perpetual licencing deal for the software, curriculum and content of Lantern, which built digital therapeutics for mental health conditions before shutting down operations last year.
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
Cigna competitors who have launched their own venture arms include Humana, Kaiser Permanente and UnitedHealthGroup's Optum division.
Omada Health, known for its Type 2 diabetes prevention, is adding new programs that reflect an expansion into managing chronic conditions such as hypertension and Type 2 diabetes.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
The CDC status gives the company's case for its program a shot in the arm at a time when Omada Health is striving to get Medicare reimbursement for virtual DPP programs.
The San Francisco digital health company now has three payers on board as investors - Humana, Kaiser Permanente Ventures, and Cigna.
How can digital health companies capture hospitals' interest? Three panelists at MedCity INVEST proffered a few suggestions.
Omada Health added Lucia Savage as it prepares to roll out its diabetes prevention program to Medicare beneficiaries in 2018.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Counsyl is shutting down its oncology business just seven months after launching the division. Some 24 jobs will be lost as the company concentrates its efforts in women's health and carrier screening.
A look at some of the hidden challenges of diabetes management and how the patient experience can be improved.
The digital health company has hired the former head of health policy at Google, Elizabeth Engel, as a consultant, as part of a series of new hires.
A doctor from Utah's largest private employer explains why the nonprofit health system selected Omada Health to expand diabetes prevention options for its patients.
AMA's president had called unproven digital health apps 21st Century's version of snake oil, and now the doctors' group is formally partnering with a digital health company for the very first time.